Abstract 631 Table 1

Summary of Demographics, TRAE and PK Parameters

Cohort12345
Total Daily Dose (mg) 30 60 105 150 195
Patients (N) 3 4 4 3 3
Median age (Range) 54 (48–56) 61 (46–78) 70 (52–77) 72 (56–72) 65 (37–75)
Male/Female 0/3 2/2 1/3 1/2 1/2
TRAE, n (Grade) 0 3 (G2) 2 (G2) 1 (G2) 6 (G2)
Mean of PK Parameters
tmax (h) 1 0.7 1.6 1.2
Cmax (ng/mL) 95 162 374 781 1875
AUClast (ng·h/mL) 200 257 819 1854 3664
t1/2 (h) 2.1 1.7 1.7 2.6
* For cohort 5, simulated data